中密控股 reported revenue of ¥0.82B for the period ended 2026-06-30, -4.2% year on year. Net income was ¥0.14B, a 16.4% net margin on a 39.5% gross margin. Free cash flow for the period was ¥0.06B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.82B | -4.2% |
| Gross profit | ¥0.32B | — |
| Operating income | ¥0.15B | — |
| Net income | ¥0.14B | -28.1% |
| Gross margin | 39.5% | Net margin 16.4% |
| Revenue Q/Q | +6.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.50B | 60.5% |
| R&D | ¥0.04B | 5.2% |
| SG&A | ¥0.13B | 15.5% |
| Tax & other | ¥0.02B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥3.50B |
| Total liabilities | ¥0.55B |
| Shareholders' equity | ¥2.95B |
| Equity / assets | 84.3% |
| Operating cash flow | ¥0.08B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.06B |
| Cash conversion (OCF / net income) | 62% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
厚普股份 ・ *ST新元 ・ 德尔股份 ・ 景嘉微 ・ 香农芯创 ・ ST合纵 ・ 杭州高新 ・ 神思电子 ・ 光力科技 ・ 濮阳惠成 ・ 万孚生物 ・ 首华燃气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies